Table 1.
Pathway/ Gene family |
Gene | Function | Freq. in NGS | Epithelial mouse model genotype | Tumour type | Reference |
---|---|---|---|---|---|---|
p53 family | TP53 | Tumour suppressor involved in apoptosis, activates DNA repair proteins, cell cycle regulation at G1/S checkpoint | 50 - 78% | p53-/- or mutant p53 mice with chemical carcinogens or mutant KRAS | Various HNSCC | Acin, Raimondi [35,36] |
TP63 | Involved in development and regulation of apoptosis | 8% | Not described | - | n/a | |
Nesprins | SYNE1,2 | Found in the outer nuclear membrane and bind to actin filaments | 24% | Not described | - | n/a |
Notch | NOTCH1,2,3 | Transmembrane proteins that are involved in development by controlling cell fate decisions by regulating interactions between adjacent cells. | 22% | NOTCH1-/- | Basel Cell Carcinoma | Nicolas [74], Agrawal [21] |
HPV Oncogenes | E6 | Degrades p53 through ubiquitination | 15% | HPV-E6/E7 with chemical carcinogens or mutant Hras | Papillomas of the lip | Schreiber [51] |
E7 | Binds pRb to free the transcription factor E2F | |||||
PI3K/AKT/mTOR | PIK3CA | Oncogene | 8% | Not described | - | n/a |
PTEN | Tumor suppressor that regulates AKT | 8% | myrAKT PTEN-/- | Dysplastic lesions in the palate, cheeks, and lips | Bian, Moral [80,82] | |
TGF-β pathway | TGF-β | Regulates proliferation and differentiation, angiogenesis, and serves as an immune modulator | Not described | TGFBR1-/- | OCC, ears, periorbital, perianal | Bian [81] |
SMAD4 | Downstream transcription factor that activates apoptosis | Not described | SMAD4-/- | OCC, lymph node mets | Bornstein [83] | |
TGFB2 | Encodes transmembrane Ser/Thr protein kinase that is activated by TGF-β, amongst other signalling molecules | Not described | Not described | - | Lu [82] | |
RAS/RAF/ MEK/MAPK |
RASSF1A | Tumour suppressor involved in DNA repair and cell cycle arrest; negative regulator of RAS | Not described | G12D mutant KRAS | Benign squamous papillomas of oral mucosa, tongue and palate | Caulin [67] |
EGFR | Epidermal growth factor receptor; downstream mediator of RAS | Not described | Not described | - | n/a | |
Cyclins | Cyclin D1 | Promotes cellular proliferation by enabling cells to enter S phase and synthesize DNA in preparation for cell division | Not described | L2-CyclinD1 | Hyperplasia of tongue, oesophagus | Mueller [76], Nakagawa [77] |
Pocket protein family | RB1 | Tumour suppressor that inhibits cell cycle (G1/S) and is involved in chromatin remodelling | 3% | pRb/p107-deficient pRB/p130-deficient | Head and neck Squamous cell carcinomas | Shin [56] |
RBL1 | Gene product p107 is a tumour suppressor involved in cell cycle regulation | pRb/p107-deficient | Head and neck Squamous cell carcinomas | Shin [56] | ||
NOLC1 | Gene product is p130, unclear function | pRb/p130-deficient | Head and neck Squamous cell carcinomas | Shin [56] | ||
Interferon regulator transcription factor family |
IRF6 | Involved in the formation of connective tissues | Not described | Not described | - | n/a |
F-box protein family | FBXW7 | Binds to cyclin E and targets it for ubiquitination to prevent progression from G1 to S phase | Not described | Not described | - | n/a |
RIPK4 | Serine/threonine protein kinase that interacts with PKC-δ and can also activate NFkappaB. | 3% | Not described | - | n/a | |
DICER1 | RNA helicase that functions as a ribonuclease in RNA interference and microRNA pathways to repress gene expression | 3% | Not described | - | n/a |
NGS = next generation sequencing.